Cannabidiol and Oxygen-Ozone Combination Induce Cytotoxicity in Human Pancreatic Ductal Adenocarcinoma Cell Lines.

PDAC gene profile cannabidiol chemo-resistance cytotoxicity migration oxygen-ozone pancreatic cancer

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
27 Sep 2020
Historique:
received: 10 06 2020
revised: 10 09 2020
accepted: 24 09 2020
entrez: 30 9 2020
pubmed: 1 10 2020
medline: 1 10 2020
Statut: epublish

Résumé

Pancreatic cancer (PC) is related to lifestyle risks, chronic inflammation, and germline mutations in

Identifiants

pubmed: 32992648
pii: cancers12102774
doi: 10.3390/cancers12102774
pmc: PMC7600087
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

N Engl J Med. 2012 Jun 28;366(26):2455-65
pubmed: 22658128
Radiat Oncol. 2019 Aug 8;14(1):141
pubmed: 31395068
Cell Death Dis. 2011 Apr 28;2:e152
pubmed: 21525939
J Cell Biochem. 2002;87(4):470-6
pubmed: 14735903
Carcinogenesis. 2013 Jan;34(1):48-57
pubmed: 23079154
Science. 2008 Sep 26;321(5897):1801-6
pubmed: 18772397
Oxid Med Cell Longev. 2015;2015:190640
pubmed: 26265981
J Cell Physiol. 2007 Oct;213(1):115-25
pubmed: 17477375
Genes Dev. 2016 Feb 15;30(4):355-85
pubmed: 26883357
Oncogene. 2018 Dec;37(49):6368-6382
pubmed: 30061636
Cancer Invest. 2016 Nov 25;34(10):536-545
pubmed: 27824512
Adv Exp Med Biol. 2014;816:129-51
pubmed: 24818722
Mol Carcinog. 2013 Jul;52(7):555-67
pubmed: 22392697
Prostate. 2019 Feb;79(2):151-159
pubmed: 30242861
Surg Pathol Clin. 2016 Dec;9(4):547-560
pubmed: 27926359
Cancer Res. 2006 Jul 1;66(13):6748-55
pubmed: 16818650
Nat Rev Clin Oncol. 2013 Jun;10(6):323-33
pubmed: 23629472
Cancer Cell. 2013 Mar 18;23(3):406-20
pubmed: 23453624
Nat Commun. 2019 Jan 9;10(1):100
pubmed: 30626869
Oncotarget. 2016 Nov 22;7(47):77543-77557
pubmed: 27769052
Oncol Res Treat. 2018;41(10):619-625
pubmed: 30286473
Target Oncol. 2016 Apr;11(2):183-95
pubmed: 26373299
Curr Pain Headache Rep. 2019 May 6;23(6):41
pubmed: 31062104
Cancer Lett. 2019 Apr 10;447:12-23
pubmed: 30660647
JAMA Oncol. 2019 Jul 1;5(7):1020-1027
pubmed: 31145418
CA Cancer J Clin. 2018 Jan;68(1):7-30
pubmed: 29313949
Transl Oncol. 2018 Oct;11(5):1065-1073
pubmed: 30005208
N Engl J Med. 2011 May 12;364(19):1817-25
pubmed: 21561347
Cancers (Basel). 2020 Apr 23;12(4):
pubmed: 32340151
Cancer Manag Res. 2015 Aug 12;7:253-64
pubmed: 26316817
Nat Rev Gastroenterol Hepatol. 2020 Mar;17(3):153-168
pubmed: 32005945
CA Cancer J Clin. 2013 Sep;63(5):318-48
pubmed: 23856911
Adv Pharmacol. 2017;80:249-289
pubmed: 28826537
PLoS One. 2017 Sep 8;12(9):e0184519
pubmed: 28886142
PLoS One. 2016 May 12;11(5):e0154016
pubmed: 27170998
Int J Cancer. 2014 Jun 1;134(11):2534-46
pubmed: 24293211
Curr Oncol. 2016 Mar;23(2):S23-32
pubmed: 27022311
Nat Commun. 2013;4:2697
pubmed: 24162189
Cancer Res. 2007 Apr 15;67(8):3853-61
pubmed: 17440100
Genes Dev. 2003 Jan 15;17(2):201-13
pubmed: 12533509
Front Oncol. 2019 Sep 10;9:874
pubmed: 31552188
FEBS Lett. 2006 Mar 20;580(7):1733-9
pubmed: 16500647
Clin Cancer Res. 2017 Apr 1;23(7):1670-1678
pubmed: 28373365
J Cancer Res Ther. 2018 Sep;14(Supplement):S719-S723
pubmed: 30249893
Arch Med Res. 2006 May;37(4):425-35
pubmed: 16624639
PLoS Med. 2010 Apr 20;7(4):e1000267
pubmed: 20422030
Clin Cancer Res. 2017 May 15;23(10):2382-2390
pubmed: 28137923
JAMA. 2018 Jun 19;319(23):2401-2409
pubmed: 29922827
Nucleic Acids Res. 2001 May 1;29(9):e45
pubmed: 11328886
Anticancer Res. 2017 Feb;37(2):425-435
pubmed: 28179287
Int J Mol Sci. 2020 Jul 29;21(15):
pubmed: 32751388
Int J Mol Sci. 2015 Oct 22;16(10):25108-20
pubmed: 26506343
Eur J Pharmacol. 2009 Jan 28;603(1-3):42-9
pubmed: 19100257
Cancer Cell. 2012 Jan 17;21(1):105-20
pubmed: 22264792
Int J Mol Sci. 2017 Jun 22;18(7):
pubmed: 28640192
Future Oncol. 2016 Aug;12(16):1929-46
pubmed: 27246628
J Immunother. 2010 Oct;33(8):828-33
pubmed: 20842054
Cancer Discov. 2012 Aug;2(8):685-93
pubmed: 22628411
Cancer Cell. 2017 Aug 14;32(2):185-203.e13
pubmed: 28810144
Cancer Discov. 2016 Feb;6(2):166-75
pubmed: 26658419
Nat Rev Cancer. 2011 Jun;11(6):393-410
pubmed: 21606941
Int J Cancer. 2008 Feb 15;122(4):742-50
pubmed: 17943729
Adv Anat Pathol. 2018 Mar;25(2):131-142
pubmed: 28914620
Pharmacol Rev. 2006 Sep;58(3):621-81
pubmed: 16968952
Front Mol Neurosci. 2019 Jan 15;11:487
pubmed: 30697147
Chemotherapy. 1990;36(2):147-54
pubmed: 2311442

Auteurs

Margherita Luongo (M)

"Maria Guarino" Foundation-AMOR No Profit Association, 80078 Pozzuoli, Italy.

Oliviero Marinelli (O)

School of Pharmacy, University of Camerino, 62032 Camerino (MC), Italy.

Laura Zeppa (L)

School of Pharmacy, University of Camerino, 62032 Camerino (MC), Italy.

Cristina Aguzzi (C)

School of Pharmacy, University of Camerino, 62032 Camerino (MC), Italy.

Maria Beatrice Morelli (MB)

School of Pharmacy, University of Camerino, 62032 Camerino (MC), Italy.

Consuelo Amantini (C)

School of Bioscience and Veterinary Medicine, University of Camerino, 62032 Camerino (MC), Italy.

Andrea Frassineti (A)

"Maria Guarino" Foundation-AMOR No Profit Association, 80078 Pozzuoli, Italy.

Marianne di Costanzo (M)

"Maria Guarino" Foundation-AMOR No Profit Association, 80078 Pozzuoli, Italy.

Alessandro Fanelli (A)

Department of Radiotherapy, Ecomedica Empoli, 50053 Empoli FI, Italy.

Giorgio Santoni (G)

School of Pharmacy, University of Camerino, 62032 Camerino (MC), Italy.

Massimo Nabissi (M)

School of Pharmacy, University of Camerino, 62032 Camerino (MC), Italy.
Integrative Therapy Discovery Lab, University of Camerino, 62032 Camerino (MC), Italy.

Classifications MeSH